Sarepta Therapeutics: Q1 Earnings Snapshot

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Wednesday reported first-quarter profit of $36.1 million.

The Cambridge, Massachusetts-based company said it had net income of 37 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, came to 73 cents per share.

The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.

The biopharmaceutical company posted revenue of $413.5 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $372.8 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on SRPT at

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up